MacCallum Caroline A, Lo Lindsay A, Pistawka Carly A, Christiansen April, Boivin Michael, Snider-Adler Melissa
Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Department of Public Health Sciences, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Front Psychiatry. 2022 Jun 24;13:883517. doi: 10.3389/fpsyt.2022.883517. eCollection 2022.
Clinicians play an important role in promoting safe and responsible medical cannabis use. One essential component to safe use is considering a patient's risk of neurocognitive impairment. However, there remains a lack of practical guidance on how clinicians can evaluate this risk for medical cannabis patients. Here, a practical framework is presented for clinicians to assess and stratify cannabis-associated impairment risk. The proposed framework is intended to practically guide healthcare providers in gaining a more comprehensive review of a patient's impairment-related factors. This framework can be used to assess impairment risk for patients currently using or considering medical cannabis and is recommended for all patients who perform safety-sensitive duties. Healthcare providers (HCP) managing patient's medical cannabis or those conducting assessments to determine risk of impairment for safety-sensitive workplaces can utilize this framework to stratify patients' risk of impairment. Such assessments can inform patient-specific needs for support, education, and guidance, to ensure cannabis is used safely and responsibly.
临床医生在促进安全、合理使用医用大麻方面发挥着重要作用。安全使用的一个重要组成部分是考虑患者发生神经认知障碍的风险。然而，对于临床医生如何评估医用大麻患者的这种风险，仍然缺乏实用的指导。在此，为临床医生提供了一个实用框架，用于评估和分层与大麻相关的损害风险。所提出的框架旨在切实指导医疗保健提供者更全面地审查与患者损害相关的因素。该框架可用于评估目前正在使用或考虑使用医用大麻的患者的损害风险，建议所有从事安全敏感工作的患者使用。管理患者医用大麻的医疗保健提供者（HCP）或那些进行评估以确定安全敏感工作场所损害风险的人员，可以利用这个框架对患者的损害风险进行分层。这样的评估可以为患者特定的支持、教育和指导需求提供信息，以确保安全、合理地使用大麻。
